Alexion Pharmaceuticals
Fabio Valentini, MSc, MBA, is a seasoned leader in the biopharmaceutical industry with extensive experience in driving development and commercialization strategies for innovative therapies in rare neurology and immunology diseases. Currently serving as Global Medicine Team Lead at Alexion Pharmaceuticals, Valentini has led multiple global program teams through various phases of development. Prior roles include founding RD&C Advisors LLC, managing new business operations at EMD Serono, and leading global product development and licensing initiatives at Merck Serono. Valentini's background is further supported by a strong academic foundation, including an MBA from Babson College and an MSc in Nutrition from The University of British Columbia, complemented by executive education in strategic leadership from Harvard.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.